MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/122.5/0.1/21.03.25 Share Price

Warrant

DE000MG4M0D2

Real-time Bid/Ask 05:42:07 26/06/2024 pm IST
0.174 EUR / 0.207 EUR +2.69% Intraday chart for MORGAN STANLEY PLC/CALL/CELSIUS HLDGS/122.5/0.1/21.03.25
Current month-69.00%
1 month-83.83%
Date Price Change
26/24/26 0.172 -7.53%
25/24/25 0.186 -19.13%
24/24/24 0.23 -11.54%
21/24/21 0.26 +4.00%
20/24/20 0.25 -10.71%

Delayed Quote Börse Stuttgart

Last update June 26, 2024 at 05:09 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN MG4M0D
ISINDE000MG4M0D2
Date issued 22/05/2024
Strike 122.5 $
Maturity 21/03/2025 (268 Days)
Parity 10 : 1
Emission price 1.41
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.31
Lowest since issue 0.172
Spread 0.023
Spread %11.86%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
55.86 USD
Average target price
83.43 USD
Spread / Average Target
+49.36%
Consensus